The leading antiviral treatments for a person with either a SARS-CoV-2 coronavirus infection or the disease it causes, COVID-19, became more accessible today.
The U.S. Food and Drug Administration (FDA) notified Pfizer Inc. and Merck Sharp & Dohme LLC on February 1, 2023, it has issued revised emergency Use Authorization (EAU) #105 and #108.
COVID-19 Antiviral Access Expedited
Has Influenza Flown South for Spring Break 2023
As vacationers plan their Spring Break 2023 plans, many ask what happened with this year's flu season.
According to reports recently published by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), the 2022-2023 flu season is ending in the Northern Hemisphere.
For example, the WHO's Influenza Update N° 437 concluded countries of North America reported most indicators of influenza activity decreased to levels similar to or below levels typically observed this time of year.